Robert H. Dworkin

Robert H. Dworkin

University of Rochester

H-index: 104

North America-United States

About Robert H. Dworkin

Robert H. Dworkin, With an exceptional h-index of 104 and a recent h-index of 59 (since 2020), a distinguished researcher at University of Rochester, specializes in the field of analgesic clinical trials, treatment of pain, prevention of pain.

His recent articles reflect a diverse array of research interests and contributions to the field:

Virtual focus groups among individuals with use disorders: assessing feasibility and acceptability in an underserved clinical population

Sedation Research in Critically Ill Pediatric Patients: Proposals for Future Study Design From the Sedation Consortium on Endpoints and Procedures for Treatment, Education, and …

Meaningful within-patient change for clinical outcome assessments: model-based approach versus cumulative distribution functions

Inadequacies in Reporting and Representation of Sex and Gender in Randomized Clinical Trials of Chronic Pain Interventions: An ACTTION COPASETIQ Review

Predicting treatment responses in patients With osteoarthritis: results from two phase III tanezumab randomized clinical trials

Psychedelics and psychotherapy: is the whole greater than the sum of its parts?

Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION review and considerations

Clinical trial design challenges and opportunities for emerging treatments for opioid use disorder: A review

Robert H. Dworkin Information

University

University of Rochester

Position

School of Medicine and Dentistry

Citations(all)

58759

Citations(since 2020)

21480

Cited By

46080

hIndex(all)

104

hIndex(since 2020)

59

i10Index(all)

280

i10Index(since 2020)

194

Email

University Profile Page

University of Rochester

Robert H. Dworkin Skills & Research Interests

analgesic clinical trials

treatment of pain

prevention of pain

Top articles of Robert H. Dworkin

Title

Journal

Author(s)

Publication Date

Virtual focus groups among individuals with use disorders: assessing feasibility and acceptability in an underserved clinical population

Frontiers in Psychiatry

Cecilia L Bergeria

Brandon Park

Prem Umang Satyavolu

Kelly E Dunn

Robert H Dworkin

...

2024/3/11

Sedation Research in Critically Ill Pediatric Patients: Proposals for Future Study Design From the Sedation Consortium on Endpoints and Procedures for Treatment, Education, and …

Pediatric Critical Care Medicine

Shawn S Jackson

Jennifer J Lee

William M Jackson

Jerri C Price

Sue R Beers

...

2024/4/1

Meaningful within-patient change for clinical outcome assessments: model-based approach versus cumulative distribution functions

Journal of Biopharmaceutical Statistics

Jinma Ren

Andrew G Bushmakin

Paul R Cislo

Lucy Abraham

Joseph C Cappelleri

...

2024/3/13

Inadequacies in Reporting and Representation of Sex and Gender in Randomized Clinical Trials of Chronic Pain Interventions: An ACTTION COPASETIQ Review

The Journal of Pain

Isabel C Shklyar

Guillermo Ceniza-Bordallo

Kavin Srinakarin

Audrey Tseng

Tonya M Palermo

...

2024/4/1

Predicting treatment responses in patients With osteoarthritis: results from two phase III tanezumab randomized clinical trials

Clinical Pharmacology & Therapeutics

Luana Colloca

Robert H Dworkin

John T Farrar

Leslie Tive

Jiyue Yang

...

2023/4

Psychedelics and psychotherapy: is the whole greater than the sum of its parts?

Clinical Pharmacology & Therapeutics

Robert H Dworkin

Michael P McDermott

Sandeep M Nayak

Eric C Strain

2023/12

Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION review and considerations

Dale Jillian Langford

Dennis C Turk

Robert H Dworkin

Jennifer S Gewandter

2023/8/2

Clinical trial design challenges and opportunities for emerging treatments for opioid use disorder: A review

Brian D Kiluk

Bethea A Kleykamp

Sandra D Comer

Roland R Griffiths

Andrew S Huhn

...

2023/1/1

Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs

Farah Z Zia

Michael H Baumann

Sean J Belouin

Robert H Dworkin

Majid H Ghauri

...

2023/4/2

Reply to “Capturing synergy holistically in psychedelic clinical trials”

Clinical Pharmacology & Therapeutics

Robert H Dworkin

Michael P McDermott

Sandeep M Nayak

Eric C Strain

2023/12/13

Real-world data and evidence in pain research: a qualitative systematic review of methods in current practice

Jan Vollert

Bethea A Kleykamp

John T Farrar

Ian Gilron

David Hohenschurz-Schmidt

...

2023/3/1

Expectations for improvement: a neglected but potentially important covariate or moderator for chronic pain clinical trials

The Journal of Pain

Dale J Langford

Raissa Lou

Soun Sheen

Dagmar Amtmann

Luana Colloca

...

2023/4/1

Control conditions in randomized trials of psychedelics: an ACTTION systematic review

Sandeep M Nayak

Melissa K Bradley

Bethea A Kleykamp

Eric C Strain

Robert H Dworkin

...

2023/5/10

Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomes

Mahd Nishtar

Remington Mark

Dale J Langford

Michael P McDermott

John D Markman

...

2023/11/14

Perspectives on participation in clinical trials among individuals with Pain, Depression, and/or anxiety: an ACTTION Scoping Review

McKenzie C Ferguson

Ewan McNicol

Bethea A Kleykamp

Karin Sandoval

Simon Haroutounian

...

2023/1/1

Examining the relationships among treatment, pain, and physical function in patients with osteoarthritis: A mediation-modeling approach

The Clinical Journal of Pain

Lucy Abraham

Robert H Dworkin

Dennis C Turk

John D Markman

David A Williams

...

2023/4/1

Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results

Sophia Linguiti

Jacob W Vogel

Valerie J Sydnor

Adam Pines

Nick Wellman

...

2023/10/5

A randomized, double-blind, placebo-controlled study of histone deacetylase type 6 inhibition for the treatment of painful diabetic peripheral neuropathy

BioPsychoSocial medicine

Pedro M Machado

Richard J Barohn

Michael McDermott

Thomas Blaettler

Thomas Lloyd

...

2023/2/1

Optimizing and accelerating the development of precision pain treatments for chronic pain: IMMPACT review and recommendations

Robert R Edwards

Kristin L Schreiber

Robert H Dworkin

Dennis C Turk

Ralf Baron

...

2023/2/1

Methods of preventing and treating pain and associated symptoms

2023/3/16

See List of Professors in Robert H. Dworkin University(University of Rochester)

Robert H. Dworkin FAQs

What is Robert H. Dworkin's h-index at University of Rochester?

The h-index of Robert H. Dworkin has been 59 since 2020 and 104 in total.

What are Robert H. Dworkin's top articles?

The articles with the titles of

Virtual focus groups among individuals with use disorders: assessing feasibility and acceptability in an underserved clinical population

Sedation Research in Critically Ill Pediatric Patients: Proposals for Future Study Design From the Sedation Consortium on Endpoints and Procedures for Treatment, Education, and …

Meaningful within-patient change for clinical outcome assessments: model-based approach versus cumulative distribution functions

Inadequacies in Reporting and Representation of Sex and Gender in Randomized Clinical Trials of Chronic Pain Interventions: An ACTTION COPASETIQ Review

Predicting treatment responses in patients With osteoarthritis: results from two phase III tanezumab randomized clinical trials

Psychedelics and psychotherapy: is the whole greater than the sum of its parts?

Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION review and considerations

Clinical trial design challenges and opportunities for emerging treatments for opioid use disorder: A review

...

are the top articles of Robert H. Dworkin at University of Rochester.

What are Robert H. Dworkin's research interests?

The research interests of Robert H. Dworkin are: analgesic clinical trials, treatment of pain, prevention of pain

What is Robert H. Dworkin's total number of citations?

Robert H. Dworkin has 58,759 citations in total.